Sorted by: Date Source

Abraxis Looks Promising in Lung Cancer War (ABII)

In BioHealth Investor - Posted 1 day ago

Abraxis BioScience, Inc. (NASDAQ: ABII) is one of the top biotech gainers this morning. The company announced that its key ABRAXANE met the primary ...

Tags: biotech clinical trial phase protein

GenVec Is Not Just a One Trick Pony

In SeekingAlpha ETFs - Posted 2 days ago

GenVec, Inc.(NASDAQ:GNVC) may be a biotech company to watch in the near term. The most immediate potential catalyst is GNVC's presentation at the ROTH...

Tags: biotech clinical trial data phase

Trouble at the Top: Roche's Avastin May Not Become the World's Top-Selling Drug

In SeekingAlpha Biotech Stocks - Posted 3 days ago

Avastin s seemingly inevitable rise to becoming the top-selling drug in the world could be under threat. Roche (RHHBY.PK) reported results Friday o...

Tags: phase

Intermune's Rise

In In the Pipeline - Posted 1 week ago

If you want to know why people continue to speculate in biotech stocks, just take a look at the stairsteppy last few days of trading in Intermune (ITM...

Tags: biotech disease health phase

High Hopes on Ariad (ARIA, MRK)

In BioHealth Investor - Posted 1 week ago

Ariad Pharmaceuticals Inc. (NASDAQ: ARIA) is seeing elevated trading today after a presentation and ahead of earnings. The difference here is that Ar...

Tags: biotech phase trading volatility

Withdrawal of Support Measures May Lead to Downgrade of Some UK Bank Ratings

In SeekingAlpha ETFs - Posted 1 week ago

As the UK financial sector slowly emerges from the recent crisis, the extraordinary support from which the country s banking system has benefited is...

Tags: phase

Abbott's Acquisition Spree

In SeekingAlpha ETFs - Posted 1 week ago

Abbott (ABT) continues to be in an acquisition mode, recently announcing its intention to acquire Facet Biotech Corporation (FACT) for $27 per share...

Tags: biotech earnings phase pipeline trading

Cancer Therapeutics: The Jury's Still Out on Pixatrone

In SeekingAlpha Biotech Stocks - Posted 1 week ago

With the announcement after yesterday's market close that Abbott Laboratories (NYSE:ABT) is buying Facet Biotech Corp. (NASDAQ:FACT) for approximately...

Tags: biotech pharma phase

Cell Therapeutics: The Jury's Still Out on Pixatrone

In SeekingAlpha Biotech Stocks - Posted 1 week ago

With the announcement after yesterday's market close that Abbott Laboratories (NYSE:ABT) is buying Facet Biotech Corp. (NASDAQ:FACT) for approximately...

Tags: biotech pharma phase

EDAP TMS, Back on the Map (EDAP)

In BioHealth Investor - Posted 1 week ago

EDAP TMS SA (NASDAQ: EDAP) is a French company which makes medical devices for the treatment of urological diseases and the company s stock is soari...

Tags: biotech clinical trial phase trading

Featured Investment Blogs

24/7 Wall St.
Insightful Analysis and Commentary for U.S. and Global Equity Investors...

Dealscape
...

Environmental Economics
Economists on Environmental and Natural Resources: News, Opinion, and Analysis...

Paul Kedrosky's Infectious Greed
Musing about technology, finance, venture capital, & the money culture with Paul Kedrosky...

Jeff Matthews Is Not Making This Up
The World of Wall Street in all its glory, and anything else that strikes our fancy. Informed observations about comp...

Stock Market Beat
Our beat is the stock market. Our job is to beat it....

TechCrunch
TechCrunch profiles the companies, products and events that are defining and transforming the new web. TechCrunch is ...

Trader Mike
Stock market commentary & trading ideas. Stock market weblog (blog), swing trading, day trading, stock picks, techni...

More Blogs